Compare Jaysynth Orgo with Similar Stocks
Dashboard
Company has a Debt to Equity ratio (avg) of 0.07 times
Healthy long term growth as Net Sales has grown by an annual rate of 190.71% and Operating profit at 73.81%
With ROCE of 12.8, it has a Very Attractive valuation with a 1.2 Enterprise value to Capital Employed
Majority shareholders : Promoters
Underperformed the market in the last 1 year
Stock DNA
Specialty Chemicals
INR 168 Cr (Micro Cap)
11.00
22
0.40%
0.13
10.97%
1.26
Total Returns (Price + Dividend) 
Latest dividend: 0.05 per share ex-dividend date: Sep-12-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Jaysynth Orgochem Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements
Jaysynth Orgochem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Sell to Hold as of 13 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but more optimistic outlook for investors.
Read full news article
Jaysynth Orgochem Ltd is Rated Sell
Jaysynth Orgochem Ltd is rated Sell by MarketsMOJO, with this rating last updated on 25 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Jaysynth Orgochem Ltd Downgraded to Sell Amid Technical Weakness and Market Underperformance
Jaysynth Orgochem Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating downgraded from Hold to Sell as of 25 June 2026. This revision reflects a combination of deteriorating technical indicators, valuation concerns, and underwhelming financial trends despite some positive quarterly results. The company’s stock has notably underperformed the broader market over the past year, prompting a reassessment of its investment appeal.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Jul-2026 | Source : BSECertificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended 30th June 2026
Closure of Trading Window
25-Jun-2026 | Source : BSEIntimation of Closure of Trading Window for Designated person & Immediate Relatives of Designated persons
Announcement under Regulation 30 (LODR)-Newspaper Publication
28-May-2026 | Source : BSECopies of Newspaper Advertisement of Extract of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March 2026
Corporate Actions 
No Upcoming Board Meetings
Jaysynth Orgochem Ltd has declared 5% dividend, ex-date: 12 Sep 25
Jaysynth Orgochem Ltd has announced 1:10 stock split, ex-date: 25 Jul 08
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 8 Schemes (0.0%)
Held by 6 FIIs (0.01%)
Parag Sharadchandra Kothari (37.27%)
Pragna Ravindra Ved (1.3%)
22.29%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 6.21% vs -0.61% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 142.92% vs -52.93% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 15.75% vs 2.40% in Sep 2024
Growth in half year ended Sep 2025 is -6.06% vs 13.60% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 13.09% vs 7.83% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -28.34% vs 30.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 13.88% vs 7.67% in Mar 2025
YoY Growth in year ended Mar 2026 is -6.15% vs 27.10% in Mar 2025






